| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |